| Robert E Robbins, MD | |
|
1107 Crown Pointe Dr, Suite C, Elizabethtown, KY 42701-7123 | |
| (270) 982-1200 | |
| (270) 234-1952 |
| Full Name | Robert E Robbins |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1107 Crown Pointe Dr, Elizabethtown, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497737324 | NPI | - | NPPES |
| 64135338 | Medicaid | KY | |
| P00626472 | Other | KY | RAILROAD MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 13533 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert E Robbins, MD 1107 Crown Pointe Dr, Suite C, Elizabethtown, KY 42701-7123 Ph: (270) 982-1200 | Robert E Robbins, MD 1107 Crown Pointe Dr, Suite C, Elizabethtown, KY 42701-7123 Ph: (270) 982-1200 |
News Archive
eZono AG, a private corporation designing, developing and distributing state of the art tablet ultrasound systems, today announced it received 510(k) clearance from the FDA for its eZono 4000 dedicated procedural guidance system with eZGuide technology, providing any plane freehand navigation.
Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this week's British Journal of Cancer.
Breckenridge Pharmaceutical, Inc.announced that it has submitted Paragraph IV (PIV) certifications for seven (7) different Abbreviated New Drug Applications (ANDA) during the 2011 calendar year and intends to submit at least five (5) each year for the next several years.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel "lipidoid" formulations for the systemic delivery of RNAi therapeutics.
A study led by researchers at The University of Texas MD Anderson Cancer Center found that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy, is a safe and effective first-line therapy for patients with high-risk large B-cell lymphoma (LBCL), a group with an urgent need for new and effective treatments.
› Verified 1 days ago
Dr. John Morrell Pendleton, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Ring Rd, Hardin Memorial Surgical Specialists, Elizabethtown, KY 42701 Phone: 270-769-5551 | |
Marshall Johnson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Ring Rd, Elizabethtown, KY 42701 Phone: 270-769-5551 Fax: 270-765-3919 | |
Thomas Taylor, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1700 Ring Rd, Elizabethtown, KY 42701 Phone: 270-769-5551 Fax: 270-765-3919 | |
Todd Y. Chadwell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Ring Rd, Elizabethtown, KY 42701 Phone: 270-769-5551 Fax: 270-765-3919 | |
Karen J Brunkhorst, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Ring Rd, Elizabethtown, KY 42701 Phone: 270-769-5551 Fax: 270-765-3919 | |
Jeffrey Austin, MD Surgery Medicare: Medicare Enrolled Practice Location: 913 N Dixie Ave, Elizabethtown, KY 42701 Phone: 270-769-5551 |